[Dalbavancin及其在耐甲氧西林金黄色葡萄球菌引起的上肢痰中的应用]。

Q3 Medicine

Klinicka mikrobiologie a infekcni lekarstvi Pub Date : 2020-06-01

Ondrej Zahornacký, Martin Novotný

{"title":"[Dalbavancin及其在耐甲氧西林金黄色葡萄球菌引起的上肢痰中的应用]。","authors":"Ondrej Zahornacký, Martin Novotný","doi":"","DOIUrl":null,"url":null,"abstract":"The article discusses dalbavancin, a relatively new lipoglycopeptide antibiotic brought to market. It briefly describes the spectrum and mechanism of its antibacterial effect and dosing regimens that can be used in the treatment of skin and soft tissue infections. The authors present a case of a patient with shoulder phlegmon caused by MRSA who was successfully treated with this antibiotic.","PeriodicalId":17909,"journal":{"name":"Klinicka mikrobiologie a infekcni lekarstvi","volume":"26 2","pages":"51-53"},"PeriodicalIF":0.0000,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Dalbavancin and its use in the treatment of methicillin-resistant Staphylococcus aureus - induced upper limb phlegmon].\",\"authors\":\"Ondrej Zahornacký, Martin Novotný\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The article discusses dalbavancin, a relatively new lipoglycopeptide antibiotic brought to market. It briefly describes the spectrum and mechanism of its antibacterial effect and dosing regimens that can be used in the treatment of skin and soft tissue infections. The authors present a case of a patient with shoulder phlegmon caused by MRSA who was successfully treated with this antibiotic.\",\"PeriodicalId\":17909,\"journal\":{\"name\":\"Klinicka mikrobiologie a infekcni lekarstvi\",\"volume\":\"26 2\",\"pages\":\"51-53\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Klinicka mikrobiologie a infekcni lekarstvi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinicka mikrobiologie a infekcni lekarstvi","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

本文介绍了一种新上市的脂糖肽类抗生素达巴文星。简要介绍了其抗菌作用的谱和机制以及可用于治疗皮肤和软组织感染的给药方案。作者提出了一个病例的病人与肩痰引起的MRSA谁是成功地用这种抗生素治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[Dalbavancin and its use in the treatment of methicillin-resistant Staphylococcus aureus - induced upper limb phlegmon].

The article discusses dalbavancin, a relatively new lipoglycopeptide antibiotic brought to market. It briefly describes the spectrum and mechanism of its antibacterial effect and dosing regimens that can be used in the treatment of skin and soft tissue infections. The authors present a case of a patient with shoulder phlegmon caused by MRSA who was successfully treated with this antibiotic.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Klinicka mikrobiologie a infekcni lekarstvi Medicine-Infectious Diseases

CiteScore

0.40

自引率

0.00%

发文量